8 December 2005
CytoFabTM licensing agreement presentation
Presenters:
Andrew Heath (CEO, Protherics)
John Rex (VP and Medical Director for Infection, AstraZeneca)
Richard Francis (Director of Process Development, Protherics)
Tony Travers (Global Brand Director for Infection, AstraZeneca)
15 September 2005
Merrill Lynch Global Pharmaceutical Conference
Presented by:
Mike Rance (VP, Corporate Affairs)
8 September 2005
Discovery seminar
Presented by:
Jan Lundberg (Executive VP, Discovery Research)
3 August 2005
SG Cowen Hot Wheels 2005
28 July 2005
Second Quarter and Half Year results 2005
Second quarter and half year results presentation - (PDF 260 kb)
16 June 2005
Goldman Sachs Healthcare Conference
31 May 2005
Carnegie Pharma Conference
10 May 2005
Exane BNP Paribas Pharma Seminar
28 April 2005
2005 Annual General Meeting
27 January 2005
2004 Fourth Quarter and Full Year Results
Not signed in
Page tools
Share price
- London
-
32.38 GBP - New York
-
50.44 USD
- Stockholm
-
368.30 SEK
At 01-Aug-2010 06:38 GMT
Detailed share priceFinancial Results
Stock symbol - AZN
Stock symbol - AZN
On LSE, NYSE and OMX
